Get the Stockscreener App
1.14
0.87%
-0.01
After Hours:
1.14
Sunshine Biopharma Inc stock is traded at $1.14, with a volume of 37,632.
It is down -0.87% in the last 24 hours and down -0.87% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.15
Open:
$1.1412
24h Volume:
37,632
Relative Volume:
0.89
Market Cap:
$5.59M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.00734
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
-7.32%
1M Performance:
-0.87%
6M Performance:
-15.87%
1Y Performance:
-51.90%
1-Day Range:
$1.12
$1.16
1-Week Range:
$1.12
$1.24
52-Week Range:
$1.12
$3.90
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.14 | 5.64M | 32.96M | -4.23M | -14.00M | -155.33 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.76 | 57.56B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
122.23 | 53.17B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.33 | 46.62B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.75 | 38.33B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
485.06 | 21.48B | 3.13B | 1.27B | 1.12B | 26.39 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Buy Signal: What are the future prospects of Sunshine Biopharma Inc Equity WarrantExit Point & Short-Term Swing Trade Alerts - baoquankhu1.vn
Sunshine Biopharma (SBFM) Board May Effect Up-to 1-for-10 Reverse Split - Stock Titan
SBFM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Gainers: Is Sunshine Biopharma Incs ROE strong enoughJuly 2025 Retail & Weekly High Momentum Picks - baoquankhu1.vn
SBFM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Retail: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentWeekly Stock Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Fund Flows: What is the Moat Score of Sunshine Biopharma IncTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Market Review: What is Sunshine Biopharma Incs valuation compared to sector2025 Historical Comparison & Expert Verified Movement Alerts - baoquankhu1.vn
SBFMW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SBFM (Sunshine Biopharma) Total Inventories : $14.06 Mil (As of Sep. 2025) - GuruFocus
Sunshine Biopharma board authorized to consider reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma board authorized to consider reverse stock split - Investing.com
Sunshine Biopharma Shareholders Approve Potential Reverse Stock Split - TipRanks
Sunshine Biopharma (SBFM) majority holder clears path for up to 1-for-10 reverse split - Stock Titan
Weekly Earnings: Will Sunshine Biopharma Inc. outperform its industry peersDollar Strength & High Win Rate Trade Alerts - mfd.ru
MSN Money - MSN
Is Sunshine Biopharma Inc. Equity Warrant benefiting from innovation trends2025 Buyback Activity & Verified Chart Pattern Signals - mfd.ru
SBFM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Sunshine Biopharma Inc. a defensive stockJuly 2025 Outlook & Breakout Confirmation Trade Signals - mfd.ru
Does Sunshine Biopharma Inc. Equity Warrant have declining or rising EPS2025 Volume Leaders & Daily Technical Stock Forecast Reports - mfd.ru
Can Sunshine Biopharma Inc. Equity Warrant stock continue upward trendQuarterly Market Review & Fast Moving Stock Trade Plans - mfd.ru
Is Sunshine Biopharma Inc. stock positioned for digital transformationJuly 2025 Trends & Reliable Price Breakout Alerts - mfd.ru
Market Outlook: Will Sunshine Biopharma Inc benefit from government policy2025 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
Sunshine Biopharma Announces Sudden Resignation of Chief Operating Officer - TipRanks
Resistance Check: Is ZIMV benefiting from innovation trendsJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Earnings Risk: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2025 Winners & Losers & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Will Sunshine Biopharma Inc. outperform its industry peersShort Setup & Reliable Intraday Trade Alerts - mfd.ru
Risk Off: What is the Moat Score of Sunshine Biopharma IncMarket Weekly Review & Expert Verified Movement Alerts - baoquankhu1.vn
Sunshine Biopharma (NASDAQ:SBFM) Trading Up 4.1% – Should You Buy? - Defense World
Growth Review: Can Sunshine Biopharma Inc. Equity Warrant reach all time highs this yearJuly 2025 Setups & Long-Term Capital Growth Ideas - baoquankhu1.vn
Sunshine Biopharma holds annual stockholders meeting - MSN
Aug Sectors: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Aug Catalysts: Why is Sunshine Biopharma Inc Equity Warrant stock going downJuly 2025 PostEarnings & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Rallies: Can VOXR sustain earnings growth2025 Breakouts & Breakdowns & Technical Pattern Alert System - baoquankhu1.vn
Panic Selling: How liquid is Sunshine Biopharma Inc stockTrade Entry Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Nasdaq Moves: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesEarnings Trend Report & AI Powered Market Trend Analysis - baoquankhu1.vn
Entry Recap: Is ARDX backed by strong institutional buyingNew Guidance & Proven Capital Preservation Tips - baoquankhu1.vn
Activity Recap: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changes2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
Is Sunshine Biopharma Inc. stock supported by innovation pipelineEarnings Summary Report & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Is Sunshine Biopharma Inc. Equity Warrant stock a defensive play in 2025July 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - Улправда
Why Sunshine Biopharma Inc. Equity Warrant stock appeals to analystsMarket Growth Review & Reliable Price Breakout Signals - Улправда
Why Sunshine Biopharma Inc. Equity Warrant stock is popular among millennialsWeekly Stock Summary & AI Enhanced Trading Signals - Улправда
Why Sunshine Biopharma Inc. stock attracts global investorsMarket Rally & Stepwise Trade Signal Implementation - ulpravda.ru
Will Sunshine Biopharma Inc. stock deliver shareholder value2025 Investor Takeaways & Verified Momentum Stock Ideas - Улправда
Why Sunshine Biopharma Inc. Equity Warrant stock is a value investor pickCup and Handle Formations & Rapid Capital Trading Tips - ulpravda.ru
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant stock a defensive play in 20252025 Market WrapUp & Reliable Trade Execution Plans - moha.gov.vn
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 2.4% – Should You Sell? - Defense World
Sunshine Biopharma (NASDAQ:SBFMW) Trading Up 27% – Here’s Why - Defense World
How Low Can Sunshine Biopharma Stock Really Go? - Trefis
Will Sunshine Biopharma Inc. Equity Warrant stock outperform international peersQuarterly Portfolio Review & Breakout Confirmation Alerts - Улправда
Why retail investors pile into Sunshine Biopharma Inc. stockJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - Улправда
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):